Publications

1. Watkins, T.C. Zelinka L.M., Kesic M, Ansevin C.F., and Walker G.R.
   "Identification of Skeletal Muscle Autoantigens by Expression Library Screening using Sera from Autoimmune Rippling Muscle Disease (ARMD) Patients. Journal of Cellular Biochemistry 99:79-87 (2006)
2. Ansevin, C.F. Treatment of ALS with Pleconaril. Neurology. March 13, 2001.
3. Ansevin, C.F., Agamanolis, D.P. Rippling Muscles and Myasthenia Gravis with Rippling Muscles. Archives of Neurology. 532:197-199, 1996
4. Ansevin, C.F. Rippling muscles and myasthenia gravis: Stretch-Activated Channelopathy. Neuromuscular Disorders. S60, 1996
5. Ansevin, C.F., Watkins, T.C., Walker, G. Rippling Muscles and Myasthenia Gravis Antibodies to Mechanosensitive Channels. Neuromuscular Disorders 8 (3,4):283-284, 1998
6. Muller-Felber, W., Ansevin, C.F., Ricker, K., Vogt, J., Muller-Jenssen, M., Goebel, H.H., Pongratz, D.E.: Immunosuppressive Treatment of Rippling Muscles in Patients with Myasthenia Gravis. Neuromuscular Disorders. Neuromuscular Disorders 9 (1999) 604-607, January 2000
7. Walker, G.R., Watkins, T., Ansevin, C.F., Identification of Autoantibodies Associated with Rippling Muscles and Myasthenia Gravis that Recognize Skeletal Muscle Proteins: Possible Relationship of Antigens and Stretch-Activated Ion Channels. Biochemical and Biophysical Research Communications. Biochemical Research Communications 264, 430-435 (1999)
8. Abel, L., Traccis, S., Dell'Osso, L., Ansevin, C.: Variable Waveforms in Downbeat Nystagmus. Annals of Neurology 13:616-620, 1983
9. Ansevin, C.F., Hoppel, C.L.,: Carnitine-Dependent Octanoyltransferase Activity is Rate-Limiting in the Mitochondrial Function in Skeletal Muscle of Dystrophic Mice. Neurology 33(Suppl 2):166, 1983 (abs.)
10. Ansevin, C.F., Hoppel, C.L.: Evidence for Carnitine Octanoyltransferase Activity in Isolated Skeletal Muscle Mitochondria. Society for Neuroscience Abstr., Vol. 8, p.993, 1982
11. Ansevin, C.F., Hoppel, C.L., Tandler, B,: Impaired Subsarcolemmal Mitochondrial Function in Skeletal Muscle of Dystrophic Mice. Fifth International Congress on Neuromuscular Diseases - Satellite Symposium on Mitchondrial Pathology in Muscle Diseases. Marseilled, France and San Remo, Italy; September, 1982. Accepted for the program but I was unable to attend.
12. Ansevin, C.F.: Invited discussion of Dr. June R. Aprille's presentation entitled "A Pathogenic Role for a Serum Factor in Reye Syndrome". Journal of National Reye Syndrome Foundation 1:44-50, 1980
13. Ansevin, C.F.: Reye Syndrome: Serum-Induced Alterations in Brain Mitochondrial Function are Blocked by Fatty Acid-Free Albumin. Neurology 30:160-166, February, 1980
14. Ansevin, C.F., Allen, J.N.: Reye Syndrome: Serum-Induced Alterations in Brain Mitochondrial Function. Neurology 29:576-577, 1979 (abs.)